Mortality after myocardial infarction in HIV-infected patients who have initiated HAART

AIDS

Volumn 21, Issue 7, 2007, Pages 873-875

  Rasmussen, Line D ^a   Gerstoft, Jan ^b   Kronborg, Gitte ^c   Larsen, Carsten S ^d   Pedersen, Gitte ^e   Obel, Niels ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PRIORITY JOURNAL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DENMARK; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS;

EID: 34147170054     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3280b07dc6     Document Type: Article

References (12)

1. Friis-Moller N, Sabin CA, Weber R, d'Arminio-Monforte A, El-Sadr WM, Reiss P, et al., the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretrovial therapy and the risk of myocardial infarction. N Engl J Med 2003; 349:1993-2003.
2. Lohse N, Hansen ABE, Jensen-Fangel S, Kronborg G, Kvinesdal B, Pedersen C, et al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV cohort study. Scand J Infect Dis 2005; 37:338-343.
3. Hansen ABE, Gerstoft J, Kronborg G, Pedersen C, Sørensen HT, Obel N. Mortality in siblings of patients co-infected with HIV and hepatitis C virus. J Infect Dis 2007; in press.
4. Frank L. Epidemiology - when an entire country is a cohort. Science 2000; 287:2398-2399.
5. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register - a valuable source of data for modern health sciences. Dan Med Bull 1999; 46:263-268.
6. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method for classifying prognostic co-morbidity in longitudinal studies: development and evaluation. J Chronic Dis 1987; 40:373-383.
7. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson co-morbidity index predicted in-hospital mortality. J Clin Epidemiol 2004; 57:1288-1294.
8. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003; 56:124-130.
9. Garoufalis S, Kouvaras G, Vitsis G, Perdouris K, Markatou P, Hatzisavas J, et al. Comparison of angiographic findings, risk factors, and long term follow-up between young and old patients with a history of myocardial infarction. Int J Cardiol 1998; 67:75-80.
10. Rosengren A, Wallentin L, Simoons M, Gitt AK, Behar S, Battler A, et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J 2006; 27:789-795.
11. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation 2000; 101:2557-2567.
12. Matetzky S, Dominingo M, Kar S, Noc M, Shah PK, Kaul S, et al. Acute Myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med 2003; 163:457-460.